National Center for Health Research https://validator.w3.org/feed/docs/rss2.html NCHR Written Public Comment to Advisory Council on Alzheimer’s Research, Care, and Services Regarding Plans for Updating the National Plan to Address Alzheimer’s Disease for 2026-2035. NCHR Written Public Comment to Advisory Council on Alzheimer’s Research, Care, and Services Jobs, Fellowships, Internships & Volunteers Key Staff Can Belly Fat Cause Cancer and Other Serious Diseases? Public Comment of Generation Patient, National Center for Health Research, Patient Safety Action Network, and USA Patient Network in response to the Medical Device User Fees Amendments (MDUFA) VI Stakeholders Process and Commitment Letter NCHR Public Comment on FDA Medical Device User Fee Amendments (MDUFA) VI for 2027-2032 FDA, In First Tobacco Action, Bans Flavors Testimony to FDA Tobacco Products Scientific Advisory Committee on Menthol Cigarettes Expedited Investigational New Drug (IND) Pilot Program- Request for Information Patient, Consumer, and Public Health Coalition Comments on Proposed Rule to Allow FDA to Regulate All Tobacco Products Nonprofit Groups’ Letter to Secretary Price on the Tobacco “Deeming Rule” NCHR Comment on the USPSTF’s Draft Recommendations for Tobacco and Nicotine Use Prevention in Children and Adolescents: Primary Care Interventions NCHR’s Comments on USPSTF Draft Research Plan: Interventions for Tobacco Cessation in Adults, Including Pregnant Women Advancing Tobacco Control Practices To Prevent Initiation of Tobacco Use Among Youth and Young Adults, Eliminate Exposure to Secondhand Smoke, and Identify and Eliminate Tobacco- Related Disparities: Request for Information. Smoking Pipe Tobacco: Exposure and Health NCHR’s Comments on FDA’s Proposed Rule on Tobacco Product Applications NCHR Comments on FDA’s Notice on the Modified Risk Tobacco Product Application for Copenhagen Snuff Fine Cut Coalition Letter Urging Support for the Reversing the Youth Tobacco Epidemic Act NCHR’s Comments on FDA’s Notice on the Modified Risk Tobacco Product Applications for IQOS System With Marlboro Heatsticks NCHR’s Comments on USPSTF’s Draft Recommendation Statement for Tobacco Smoking Cessation in Adults, Including Pregnant Persons NCHR’s Comments on the Petition for Extension of Premarket Tobacco Product Application Filing Deadline from Keller and Heckman LLP NCHR’s Comments on Modified Risk Tobacco Product Application for Camel Snus NCHR Comments on Regulating Menthol in Tobacco Products FDA official bolting to Big Tobacco shines a light on the agency’s revolving-door problem Testimony of Dr. Diana Zuckerman at the Tobacco Products Scientific Advisory Committee Meeting on General Snus Breast implant removal is more popular than ever. Why? NCHR Public Comment on the Continued Implementation of the National Youth Tobacco Survey Testimony of Dr. Diana Zuckerman at the FDA Advisory Committee Meeting on Risks of 3 Heat Sticks And Other IQOS Tobacco Products NCHR Written Comment to FDA on Modified Risk Tobacco Product (MRTP) Applications for ZYN Nicotine Pouch Products NCHR Written Comment to FDA on the National Youth Tobacco Survey Testimony of Dr. Akashleena Mallick at the FDA TPSAC Meeting on ZYN Nicotine Pouch Products Submitted by Swedish Match U.S.A, Inc. Biennial Reports & Newsletters NCHR Letter to Sen. Sanders in Support of the Childhood Diabetes Reduction Act NCHR Written Comment to OMB on the Proposed Regulation for Federal Financial Assistance NCHR Written Comment to NIH on Post-Trial Needs and Informed Consent for Research Participants Receiving Investigational Implantable Devices Artificial Sweeteners: Do They Help You Lose Weight or Gain it? Are they Safe? NCHR Written Comment to FDA on the Commissioner’s National Priority Voucher (CNPV) Pilot Program NCHR Written Comment to FDA on the Plausible Mechanism Framework for Developing Individualized Therapies for Genetic Conditions NCHR Written Comment to AHRQ on Improving the Management of Menopausal Symptoms in Perimenopausal and Early Postmenopausal Women NCHR Comments On FDA’s Requirements for Tobacco Product Manufacturing Practices Eating Habits That Improve Health and Help with Weight Loss and BMI Everything You Need To Know About The New Weight Loss Drugs Makary departs FDA amid turmoil as Diamantas, agency’s top food official, steps in Can the Shingles Vaccine Lower the Chance of Dementia or Alzheimer’s? Testimony of Dr. Diana Zuckerman at the FDA Oncology Drugs Advisory Committee on TRUQAP Testimony of Dr. Diana Zuckerman at the FDA Oncology Drugs Advisory Committee on Breast Cancer Next FDA chief to face similar headwinds after Makary’s ouster F.D.A. Commissioner Marty Makary Resigns After Weeks of Pressure The National Center for Health Research